CAM
TWST icon

ClariVest Asset Management’s Twist Bioscience TWST Stock Holding History

ClariVest Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$363K Hold
7,371
– – 0.04% 365
2024
Q2 		$363K Buy
+7,371
New +$301K 0.04% 365

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClariVest Asset Management's TWST Position: Q3 2024 in Review

ClariVest Asset Management held its Twist Bioscience (TWST) position steady in Q3 2024 at 7,371 shares worth $363K. The position accounts for 0.04% of the portfolio, ranked #365.

ClariVest Asset Management first reported a position in TWST in Q2 2024 and has held it in 2 quarters since. 246 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

  • ClariVest Asset Management held 7,371 shares of Twist Bioscience worth $363K as of Q3 2024.
  • ClariVest Asset Management left its Twist Bioscience share count unchanged in Q3 2024.
  • Twist Bioscience made up 0.04% of ClariVest Asset Management's portfolio in Q3 2024, its #365 holding.
  • ClariVest Asset Management first reported a position in Twist Bioscience in Q2 2024 and has held it in 2 quarters since.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.